<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pathology News | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/posts/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Mon, 13 Apr 2026 12:24:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Pathology News | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow</title>
		<link>https://tissuepathology.com/2026/04/13/tribun-health-calopix-connect-an-open-api-to-integrate-ai-into-the-digital-pathology-workflow/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 13 Apr 2026 12:24:14 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Data Management]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Web/Tech]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Aiforia]]></category>
		<category><![CDATA[case management]]></category>
		<category><![CDATA[DeepPath]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[IBEX]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Open API]]></category>
		<category><![CDATA[Owkin]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Primaa]]></category>
		<category><![CDATA[Qritive]]></category>
		<category><![CDATA[slide visualization]]></category>
		<category><![CDATA[Tribune Health]]></category>
		<category><![CDATA[workflow organization]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24346</guid>

					<description><![CDATA[<p>From the Tribun Health blog: Discover CaloPix Connect, Tribun Health’s open API to seamlessly integrate AI into pathology workflows, without disruption or added complexity. Artificial Intelligence is rapidly transforming pathology. Automated metastasis detection, biomarker quantification, scoring assistance, therapeutic prediction—the use cases are multiplying and paving the way for faster, more precise diagnoses. Yet one major challenge [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/13/tribun-health-calopix-connect-an-open-api-to-integrate-ai-into-the-digital-pathology-workflow/">Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor</title>
		<link>https://tissuepathology.com/2026/04/10/proscia-why-precision-medicine-needs-an-enterprise-digital-pathology-backbone-not-just-a-vendor/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 10 Apr 2026 12:19:08 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Laboratory Information Systems]]></category>
		<category><![CDATA[Laboratory Management & Operations]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24344</guid>

					<description><![CDATA[<p>From the Proscia blog: How Proscia’s Concentriq platform transforms fragmented workflows into a scalable, AI-ready engine for precision medicine growth. Precision medicine is the frontier of modern oncology. Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient outcomes. However, the [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/04/10/proscia-why-precision-medicine-needs-an-enterprise-digital-pathology-backbone-not-just-a-vendor/">Proscia: Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Indica Labs: Learn How HALO Macrodissection Solutions Quantifies Tumor Content and Guides ROI Selection</title>
		<link>https://tissuepathology.com/2026/03/23/indica-labs-learn-how-halo-macrodissection-solutions-quantifies-tumor-content-and-guides-roi-selection/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 23 Mar 2026 12:56:56 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Clinical Pathology]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Colorectal Cancer]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Macrodissection]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[prostate cancer]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24301</guid>

					<description><![CDATA[<p>Indica Labs: HALO Macrodissection Solutions harness the power of AI to quantify and visualize tumor content to improve the reliability of downstream molecular testing in lung, colorectal, breast, and prostate cancers. Accurate estimation of tumor content is a critical step in preparing tissue samples for downstream molecular analysis. Variability in manual assessment can affect the [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/03/23/indica-labs-learn-how-halo-macrodissection-solutions-quantifies-tumor-content-and-guides-roi-selection/">Indica Labs: Learn How HALO Macrodissection Solutions Quantifies Tumor Content and Guides ROI Selection</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Leica Biosystems Accelerates Aperio AI Store Growth, Expands AI-Tools, and Welcomes Mindpeak to Its Growing Ecosystem</title>
		<link>https://tissuepathology.com/2026/03/20/leica-biosystems-accelerates-aperio-ai-store-growth-expands-ai-tools-and-welcomes-mindpeak-to-its-growing-ecosystem/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 20 Mar 2026 13:00:07 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AI tools]]></category>
		<category><![CDATA[Aperio AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[leica biosystems]]></category>
		<category><![CDATA[Mindpeak]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24296</guid>

					<description><![CDATA[<p>VISTA, California — March 19, 2026 — Leica Biosystems, a Danaher company and a global leader in digital and anatomic pathology solutions, announces major expansion of the Aperio AI Store, reinforcing its momentum as a rapidly growing gateway to a curated menu of leading AI tools, seamlessly embedded in a single interface. Designed to enhance accuracy, reduce turnaround times, [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/03/20/leica-biosystems-accelerates-aperio-ai-store-growth-expands-ai-tools-and-welcomes-mindpeak-to-its-growing-ecosystem/">Leica Biosystems Accelerates Aperio AI Store Growth, Expands AI-Tools, and Welcomes Mindpeak to Its Growing Ecosystem</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>March Webinar by Indica Labs</title>
		<link>https://tissuepathology.com/2026/03/16/march-webinar-by-indica-labs/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 16 Mar 2026 13:30:26 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Training]]></category>
		<category><![CDATA[Webinars]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[cell population discovery]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[high dimensional analysis]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[webinar]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24287</guid>

					<description><![CDATA[<p>Indica Labs: Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images! Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis Date: 31 March 2026 Time: 7:00 – 8:00 PDT &#124; 10:00 – 11:00 EDT &#124; 15:00 – 16:00 BST Location: Webinar Register Now Summary Multiplexed imaging generates rich datasets where [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/03/16/march-webinar-by-indica-labs/">March Webinar by Indica Labs</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies</title>
		<link>https://tissuepathology.com/2026/03/13/proscia-what-proscias-top-klas-ratings-mean-for-life-sciences-companies/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 13 Mar 2026 14:34:12 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[2026 KLAS Digital Pathology Report]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Global 2026 Best in KLAS]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Life sciences]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Proscia]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24285</guid>

					<description><![CDATA[<p>The latest from the Proscia blog: By Ritida Nanda &#124; March 12, 2026 Proscia has been named Global 2026 Best in KLAS for Digital Pathology in Europe and earned the top performance score in the U.S. in the 2026 KLAS Digital Pathology Report. Here’s why life sciences organizations should take notice. Every clinical trial with a [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/03/13/proscia-what-proscias-top-klas-ratings-mean-for-life-sciences-companies/">Proscia: What Proscia’s Top KLAS Ratings Mean for Life Sciences Companies</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
